| New insight into microRNA functions in cancer: oncogene–microRNA–tumor suppressor gene network K Zhou, M Liu, Y Cao Frontiers in molecular biosciences 4, 46, 2017 | 135 | 2017 |
| JAK1/2 and BCL2 inhibitors synergize to counteract bone marrow stromal cell–induced protection of AML R Karjalainen, T Pemovska, M Popa, M Liu, KK Javarappa, MM Majumder, ... Blood, The Journal of the American Society of Hematology 130 (6), 789-802, 2017 | 122 | 2017 |
| Analysis of 20 genes at chromosome band 12q13: RACGAP1 and MCRS1 overexpression in nonsmall‐cell lung cancer Y Liang, M Liu, P Wang, X Ding, Y Cao Genes, Chromosomes and Cancer 52 (3), 305-315, 2013 | 70 | 2013 |
| MCRS1 overexpression, which is specifically inhibited by miR-129*, promotes the epithelial-mesenchymal transition and metastasis in non-small cell lung cancer MX Liu, KC Zhou, Y Cao Molecular cancer 13, 1-15, 2014 | 62 | 2014 |
| MicroRNA-944 affects cell growth by targeting EPHA7 in non-small cell lung cancer M Liu, K Zhou, Y Cao International journal of molecular sciences 17 (10), 1493, 2016 | 46 | 2016 |
| Elevated expression of S100A8 and S100A9 correlates with resistance to the BCL-2 inhibitor venetoclax in AML R Karjalainen, M Liu, A Kumar, L He, D Malani, A Parsons, M Kontro, ... Leukemia 33 (10), 2548-2553, 2019 | 34 | 2019 |
| The candidate oncogene (MCRS1) promotes the growth of human lung cancer cells via the miR–155–Rb1 pathway M Liu, K Zhou, Y Huang, Y Cao Journal of Experimental & Clinical Cancer Research 34, 1-12, 2015 | 31 | 2015 |
| ERGIC 3, which is regulated by miR‐203a, is a potential biomarker for non‐small cell lung Cancer QH Lin, KD Zhang, HX Duan, MX Liu, WL Wei, Y Cao Cancer science 106 (10), 1463-1473, 2015 | 21 | 2015 |
| Frequent loss of heterozygosity on chromosome 12q in non-small-cell lung carcinomas XJ Ding, MX Liu, L Ao, YR Liang, Y Cao Virchows Archiv 458, 561-569, 2011 | 9 | 2011 |
| Combined targeting of BET family proteins and BCL2 Is synergistic in acute myeloid leukemia cells overexpressing S100A8 and S100A9 R Karjalainen, M Liu, A Kumar, A Parsons, L He, DR Malani, M Kontro, ... Blood 132, 2634, 2018 | 2 | 2018 |
| Targeting of JAK/STAT Signaling to Reverse Stroma-Induced Cytoprotection Against BCL2 Antagonist Venetoclax in Acute Myeloid Leukemia R Karjalainen, M Popa, M Liu, M Kontro, MM Safont, A Parsons, K Porkka, ... Blood 128 (22), 32, 2016 | 1 | 2016 |
| Elevated Expression of the S100A8/S100A9 Complex in AML Correlates with Reduced Sensitivity to the BCL2 Inhibitor Venetoclax R Karjalainen, M Liu, A Kumar, A Parsons, M Kontro, K Porkka, ... Blood 130, 298, 2017 | | 2017 |
| STROMA-DERIVED FACTORS STIMULATE JAK/STAT SIGNALING IN AML CELLS RESULTING IN RESISTANCE TO BCL2 INHIBITOR VENETOCLAX R Karjalainen, M Popa, M Liu, KK Javarappa, M Kontro, A Parsons, ... HAEMATOLOGICA 102, 39-39, 2017 | | 2017 |
Kecheng ZhouUniversity of HelsinkiVerified email at helsinki.fi
